Company profile

Resonance Health Analysis Services Pty Ltd

Resonance Health Analysis Services Pty Ltd has 4 AI-enabled medical devices on the FDA list. The first decision was on November 30, 2018 and the most recent on June 20, 2023 (HepaFatSmart (V2.0.0)). Its most common review panel is Radiology (4 devices).

4AI devices

2018First decision

2023Latest decision

1Specialties

Per year

2018202020212023

Resonance Health Analysis Services Pty Ltd AI devices per year: 2018 1, 2020 1, 2021 1, 2023 1

By specialty

Radiology4

Related guides

Top radiology devices

Timeline

June 20, 2023 · 510(k) K231459HepaFatSmart (V2.0.0) · Radiology · LNH
December 29, 2021 · 510(k) K213776LiverSmart · Radiology · PCS
December 7, 2020 · 510(k) K201039HepaFat-AI · Radiology · LNH
November 30, 2018 · 510(k) K182218FerriSmart Analysis System · Radiology · PCS